Trump announces trade deal with EU following months of negotiations
Torchmark Corporation (NYSE:GL)’s stock soared to a 52-week high, reaching a price level of $128.93 USD. With a market capitalization of $10.7 billion and trading at an attractive P/E ratio of 10.7, InvestingPro analysis suggests the stock remains undervalued despite the recent surge. This peak reflects a notable milestone for the company, showcasing a period of robust performance amidst a challenging economic landscape. The stock has demonstrated impressive momentum, posting a 21.7% return over the past six months and a 14.5% gain year-to-date. This strong performance indicates a steady trajectory for the insurer, as it continues to navigate through the dynamic financial markets. Investors are keeping a close watch on the company’s strategic moves and financial health, as it sustains its upward trend and reinforces its market position. For deeper insights into Torchmark’s valuation and growth prospects, access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Globe Life Inc. reported its fourth-quarter 2024 earnings, exceeding analysts’ expectations with an earnings per share (EPS) of $3.14, surpassing the forecasted $3.12. However, the company’s revenue slightly missed the mark, coming in at $1.47 billion against an anticipated $1.48 billion. CFRA analyst Catherine Seifert raised the price target for Globe Life shares from $118.00 to $130.00 while maintaining a Hold rating, driven by the company’s strong fourth-quarter performance and increased earnings per share estimates for 2025 and 2026. TD Cowen reiterated a Buy rating on Globe Life, maintaining a price target of $168.00, citing positive trends in new business and capital, as well as strong statutory earnings and cash flow.
The company also announced the expansion of its board of directors, appointing two new independent directors, Matthew J. Adams and Philip M. Jacobs, to bolster its governance structure. These appointments were disclosed in a recent SEC filing. The analysts at TD Cowen highlighted the potential establishment of a Bermuda captive as a significant opportunity to enhance Globe Life’s long-term deployable capital. Meanwhile, Globe Life’s management has expressed optimism about continued growth in 2025, with strong guidance for life and health premium revenues. As the company continues its strategic initiatives, it remains focused on share repurchase programs, having spent $946 million on buybacks in 2024.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.